These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9458463)

  • 1. Lipid-lowering with statins and fibrinolytic parameters.
    Jovin IS; Heidinger K; Taborski U; Muller-Berghaus G
    Eur Heart J; 1997 Sep; 18(9):1516. PubMed ID: 9458463
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of low-density-lipoprotein lowering with statins.
    Seidel D; Cremer P
    Lancet; 1994 Sep; 344(8923):683. PubMed ID: 7915367
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.
    Rosenson RS; Tangney CC
    JAMA; 1998 May; 279(20):1643-50. PubMed ID: 9613915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein and lipids may respond differently to statins.
    Black DM
    Curr Atheroscler Rep; 2003 Jan; 5(1):9. PubMed ID: 12562533
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomized comparative study of the effects of treatment with once-daily, niacin extended-release/lovastatin and with simvastatin on lipid profile and fibrinolytic parameters in Taiwan.
    Lin TH; Voon WC; Yen HW; Huang CH; Su HM; Lai WT; Sheu SH
    Kaohsiung J Med Sci; 2006 Jun; 22(6):257-65. PubMed ID: 16793562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins as immunomodulatory drugs.
    Górski A; Kasprzycka M; Nowaczyk M; Wierzbicki P; Korczak-Kowalska G; Jezak P; Kłosowska D; Ekiert A; Kłodos K
    Adv Exp Med Biol; 2001; 495():283-8. PubMed ID: 11774580
    [No Abstract]   [Full Text] [Related]  

  • 7. Implications of 4S evidence on baseline lipid levels.
    Ravnskov U
    Lancet; 1995 Jul; 346(8968):181. PubMed ID: 7603244
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of low-density-lipoprotein lowering with statins.
    Leufkens HG; Herings RM; Urquhart J
    Lancet; 1994 Sep; 344(8923):683-4. PubMed ID: 7915368
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes.
    Krysiak R; Okopień B; Herman Z
    Drugs; 2003; 63(17):1821-54. PubMed ID: 12921488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of low-density-lipoprotein lowering with statins.
    Marshall S; Meredith PA; Elliott HL
    Lancet; 1994 Sep; 344(8923):684. PubMed ID: 7915369
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells.
    Suades R; Padró T; Alonso R; Mata P; Badimon L
    Thromb Haemost; 2013 Aug; 110(2):366-77. PubMed ID: 23740299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of low-density-lipoprotein lowering with statins.
    Rosenson RS; Stein JH
    Lancet; 1994 Sep; 344(8923):683. PubMed ID: 7915366
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role of HDL in the prevention of cardiovascular events].
    Paragh G; Harangi M
    Orv Hetil; 2001 Jan; 142(3):121-6. PubMed ID: 11217160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Kidney and statins].
    Moulin B; Caillard S
    Ann Endocrinol (Paris); 2001 Feb; 62(1 Pt 2):121-7. PubMed ID: 11240414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Statins: similarities and differences in the pharmacological, clinical and laboratory aspects].
    Motti C; Gnasso A; Cortese C
    Ann Ital Med Int; 2000; 15(1):96-102. PubMed ID: 10842898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ezetimibe/simvastatin combination on metabolic parameters.
    Filippatos TD; Elisaf MS
    Int J Cardiol; 2016 Jan; 202():273-4. PubMed ID: 26408840
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipid-lowering agents may fight cancer by denying it LDL.
    Firestone RA
    Int J Cancer; 2006 Nov; 119(10):2497. PubMed ID: 16858681
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety of lovastatin/extended release niacin compared with lovastatin alone, atorvastatin alone, pravastatin alone, and simvastatin alone (from the United States Food and Drug Administration adverse event reporting system).
    Alsheikh-Ali AA; Karas RH
    Am J Cardiol; 2007 Feb; 99(3):379-81. PubMed ID: 17261402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins and the kidney.
    Wheeler DC
    Curr Opin Nephrol Hypertens; 1998 Sep; 7(5):579-84. PubMed ID: 9818207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins and the assessment of endothelial function.
    Lee KW; Felmeden DC; Lip GY
    J Intern Med; 2002 May; 251(5):452-3; author reply 453-4. PubMed ID: 11982746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.